Related Experiment Videos
[Membrane receptors and cell transformation]
1Department of Genetics, University of Tokyo.
Abstract:
Here I discuss quantitative and qualitative activation of several receptor-type molecules in tumor cells. Recently we have shown that EGF-R gene is frequently mutated in human glioblastoma. Mutant EGF-R had a 801-bp deletion within the ligand binding domain, and showed a ligand-independent, constitutive elevation of tyrosine kinase activity. This EGF-R mutation is detected only in glioma and associated with gene amplification, suggesting a relationship in the molecular mechanism between deletion mutation and initiation of gene amplification in these cases. Secondly I have shown an activation of mouse CD43 gene by amplification and rearrangement in erythroleukemia cell lines. Intracellular domain of CD43 has no kinase domain but a highly conserved structure among mammals, probably interacting with intracellular signal transducers. Recently CD43 has been demonstrated to be specifically associated with a cell-adhesion molecule ICAM-1. Thus, CD43-ICAM-1 system might be a new type of cytokine system which regulate cell-proliferation through cell-cell interaction. In addition, activation of EpoR and v-mpl is also discussed.
Insights
This study explores receptor-type molecule activation in tumors, detailing EGF-R mutations in glioblastoma and CD43 gene activation in erythroleukemia, suggesting new insights into cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Tumor cells exhibit quantitative and qualitative activation of receptor-type molecules.
- Recent findings highlight mutations in the Epidermal Growth Factor Receptor (EGFR) gene in human glioblastoma.
- The study also examines the activation of the CD43 gene in mouse erythroleukemia cell lines.
Purpose:
- To discuss the quantitative and qualitative activation of specific receptor-type molecules in tumor cells.
- To investigate the molecular mechanisms underlying EGFR mutations and gene amplification in glioma.
- To explore the role of CD43 gene activation and its potential interaction with ICAM-1 in cell proliferation.
Summary:
- Mutations in the EGFR gene, characterized by an 801-bp deletion in the ligand-binding domain, lead to ligand-independent tyrosine kinase activity in glioblastoma.
- This EGFR mutation, exclusively found in glioma, is associated with gene amplification, suggesting a link between deletion mutation and amplification initiation.
- Activation of the mouse CD43 gene via amplification and rearrangement in erythroleukemia cell lines is presented. The CD43-ICAM-1 system may regulate cell proliferation through cell-cell interaction, functioning as a novel cytokine system.
Impact:
- Provides insights into the molecular mechanisms of glioblastoma development driven by EGFR mutations.
- Identifies a potential new cytokine system involving CD43-ICAM-1 that regulates cell proliferation.
- Contributes to understanding gene activation and its role in hematological malignancies like erythroleukemia.